[REGN] YoY Quarter Result on 31-Mar-2015 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
07-May-2015
Financial Year
2015
Quarter
31-Mar-2015 [#Q1]
Profit Trend
QoQ- -31.00%
YoY- 16.16%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Revenue 1,511,485 1,318,991 1,200,849 869,612 625,740 439,664 231,789 36.66%
PBT 585,398 432,289 330,151 276,523 175,263 141,831 11,651 92.03%
Tax 107,418 183,358 164,415 200,502 109,820 42,957 -610 -
NP 477,980 248,931 165,736 76,021 65,443 98,874 11,651 85.66%
Tax Rate -18.35% -42.42% -49.80% -72.51% -62.66% -30.29% 5.24% -
Total Cost 1,033,505 1,070,060 1,035,113 793,591 560,297 340,790 220,138 29.38%
Ratio Analysis
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
NP Margin 31.62 18.87 13.80 8.74 10.46 22.49 5.03 35.83%
Per Share
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
EPS 4.44 2.36 1.74 0.74 0.69 1.02 0.12 82.49%
EPS Diluted 4.16 2.16 1.59 0.66 0.61 0.90 0.11 83.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.